Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Submitted by
admin
on October 24, 2011 - 11:00am
Source:
Yahoo/AP
News Tags:
Abbott Laboratories
Biogen Idec
MS
multiple sclerosis
daclizumab
Headline:
Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Do Not Allow Advertisers to Use My Personal information
